Investment ThemesDetailed Quotes
Weight Loss Drugs Watchlist

GLP-1 weight-loss drug, whose full name is Glucagon-like peptide-1 receptor agonist. Initially, GLP-1 was a hormone secreted by the gastrointestinal tract mainly used for treating diabetes, but it has also been used to suppress appetite and control weight.

  • 1547.475
  • -29.003-1.84%
Close Mar 25 16:00 ET
1585.698High1540.072Low
Constituent Stocks: 7Top Rising: LLY-1.45%
Intraday
  • 5D
  • Daily
  • Weekly
  • Monthly
  • 1Q
  • 1Y
Constituent Stocks
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
WatchlistPaper Trade
LLYEli Lilly and Co
852.350-12.550-1.45%2.67M2.29B869.550864.900874.920847.920808.02B806.10B947.99M945.74M+3.63%+3.43%-5.48%+7.31%-3.46%+10.97%+10.60%0.61%0.28%72.7972.793.12%Drug Manufacturers - General
PFEPfizer
25.550-0.590-2.26%47.61M1.22B26.16026.14026.20025.510144.80B144.58B5.67B5.66B-2.89%-1.69%-4.45%-2.87%-8.86%-1.01%-2.10%6.58%0.84%18.1218.122.64%Drug Manufacturers - General
NVONovo-Nordisk A/S
73.600-1.730-2.30%8.90M659.72M75.88075.33076.05073.200326.83B234.78B4.44B3.19B-9.11%-5.77%-19.08%-15.76%-38.19%-42.75%-14.44%1.87%0.28%22.4922.493.78%Drug Manufacturers - General
AMGNAmgen
306.860-7.520-2.39%2.57M789.55M313.980314.380314.220303.510164.85B164.38B537.20M535.68M-3.70%-3.77%-2.78%+16.96%-3.23%+12.61%+18.69%2.93%0.48%40.5940.593.41%Drug Manufacturers - General
ALTAltimmune
5.890-0.160-2.64%1.59M9.39M6.0106.0506.0365.840453.61M449.61M77.01M76.34M+4.99%+11.98%-0.34%-21.99%-4.07%-30.95%-18.31%--2.08%LossLoss3.23%Biotechnology
GPCRStructure Therapeutics
20.340-0.710-3.37%737.01K15.05M21.68021.05021.68020.1001.17B1.01B57.34M49.65M-3.65%-0.93%-3.56%-28.00%-53.66%-52.93%-25.00%--1.48%LossLoss7.51%Biotechnology
VKTXViking Therapeutics
27.980-1.300-4.44%2.44M68.63M29.51029.28029.56027.7603.14B3.07B112.25M109.77M-5.02%+5.51%-1.20%-33.93%-55.80%-59.56%-30.47%--2.22%LossLoss6.15%Biotechnology

News

Comments

Read more